+ Follow Novartis Tag
Novartis
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 2030241
[Title] => The Filipino 'Mabuhay,' bayanihan and Swiss innovation
[Summary] => The Swiss ambassador reflects on Filipinos' spirit and shares how the effects of the pandemic strengthened the ties between the Philippines and Switzerland.
[DatePublished] => 2020-07-24 06:30:00
[ColumnID] => 136541
[Focus] => 1
[AuthorID] => 1806850
[AuthorName] => Alain Gaschen
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 1816031
[Title] => Novartis general counsel resigns over deal with Trump lawyer
[Summary] => Swiss pharmaceutical giant Novartis said yesterday that its top lawyer is stepping down over a deal to hire US President Donald Trump's personal lawyer, Michael Cohen, as a consultant.
[DatePublished] => 2018-05-17 02:20:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] => http://media.philstar.com/images/articles/michael-cohen_2018-05-16_22-42-25_thumbnail.jpg
)
[2] => Array
(
[ArticleID] => 1529299
[Title] => FDA OKs first generic for Gleevec leukemia pill
[Summary] => U.S. regulators have approved a generic version of one of the first very effective — and expensive — cancer drugs, Gleevec (GLEE'-vek).
[DatePublished] => 2015-12-04 11:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => http://media.philstar.com/images/the-philippine-star/world/20151205/Blood-Vessels-Red-Blood-Cells.jpg
)
[3] => Array
(
[ArticleID] => 1416309
[Title] => FDA approves 2nd vaccine against meningitis strain
[Summary] => Federal health regulators have approved a second vaccine to prevent a strain of bacteria that can cause deadly cases of meningitis.
[DatePublished] => 2015-01-24 07:02:26
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[4] => Array
(
[ArticleID] => 1344307
[Title] => Access program helps poor cancer patients get treatment
[Summary] => A patient support group has lauded Novartis Healthcare Philippines for its unprecedented access program that helps underprivileged patients get the cancer treatments they need.
[DatePublished] => 2014-07-10 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] => http://media.philstar.com/images/the-philippine-star/business/science-and-technology/20140710/Max-Philippines-Novartis-Healthcare.jpg
)
[5] => Array
(
[ArticleID] => 1323092
[Title] => Novartis leads Thalassemia Day observance
[Summary] => Novartis Healthcare Philippines partnered with patient support group Balikatang Thalassemia (Ba-Tha) and the Quezon City Health Department to lead the country’s observance of World Thalassemia Day (WTD).
[DatePublished] => 2014-05-15 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 1305215
[Title] => Visually impaired Pinoys to hit over 2 M this year – study
[Summary] => More than two million Filipinos are projected to develop visual impairment this year due to various reasons, ranging from chronic illnesses to aging, an expert from the Philippine Academy of Opthalmology (PAO) said yesterday.
[DatePublished] => 2014-03-26 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[7] => Array
(
[ArticleID] => 1302772
[Title] => Novartis partners with PHC on clinical research
[Summary] => Novartis Healthcare Philippines and the Philippine Heart Center (PHC) have signed a memorandum of agreement (MOA) to establish a Center of Excellence for Clinical Trials that aims to enhance the hospital’s capabilities in conducting and participating in clinical trials that adhere to international ethical standards.
[DatePublished] => 2014-03-20 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 1297439
[Title] => Novartis, DOH vow to hasten progress in leprosy control
[Summary] => The Department of Health (DOH) and research-based Swiss healthcare company Novartis have vowed to continue their partnership in order to speed up the country’s progress in leprosy control.
[DatePublished] => 2014-03-06 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[9] => Array
(
[ArticleID] => 1284392
[Title] => Novartis, DOH lead country’s World Leprosy Day observance
[Summary] => The Department of Health (DOH) and research-based Swiss healthcare company Novartis have vowed to continue their partnership in order to speed up the country’s progress in leprosy control.
[DatePublished] => 2014-01-30 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
December 4, 2015 - 11:00am
January 24, 2015 - 7:02am
January 30, 2014 - 12:00am
